• 1. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 2. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 3. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 4. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 5. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002

3-(4-Methylcyclohex-3-en-1-yl)butanoic Acid: A Comprehensive Overview

3-(4-Methylcyclohex-3-en-1-yl)butanoic acid, identified by the CAS number 64740-38-1, is a compound of significant interest in the fields of organic chemistry and pharmacology. This compound, with its unique structure, has garnered attention due to its potential applications in drug discovery and material science. The molecule consists of a butanoic acid group attached to a substituted cyclohexene ring, which imparts it with distinctive chemical properties.

The structure of 3-(4-methylcyclohex-3-en-1-yl)butanoic acid is characterized by a cyclohexene ring with a methyl substituent at the 4-position and a double bond between carbons 3 and 4. The butanoic acid group is attached at the 1-position of the cyclohexene ring. This arrangement creates a molecule with both hydrophobic and hydrophilic regions, making it versatile for various chemical reactions and biological interactions.

Recent studies have highlighted the potential of this compound in pharmacological applications. Researchers have explored its role as a precursor in the synthesis of bioactive molecules, including antibiotics and anti-inflammatory agents. The cyclohexene ring's reactivity has been particularly useful in constructing complex molecular frameworks, which are essential for drug development.

In terms of synthesis, 3-(4-methylcyclohex-3-en-1-yl)butanoic acid can be prepared through several routes, including alkylation and coupling reactions. These methods leverage the molecule's functional groups to facilitate efficient construction of the desired structure. The choice of synthetic pathway often depends on the availability of starting materials and the desired scale of production.

The physical properties of this compound are also noteworthy. It has a melting point of approximately 85°C and is sparingly soluble in water, making it suitable for applications that require controlled release or targeted delivery systems. Its stability under various conditions has been tested, showing promise for use in both laboratory settings and industrial processes.

From an environmental perspective, understanding the biodegradability and toxicity of 3-(4-methylcyclohex-3-en-1-yl)butanoic acid is crucial. Preliminary studies suggest that it undergoes moderate biodegradation under aerobic conditions, which aligns with current eco-friendly trends in chemical manufacturing. However, further research is needed to fully assess its environmental impact.

In conclusion, 3-(4-methylcyclohex-3-en-1-yl)butanoic acid (CAS No. 64740-38-1) represents a valuable compound with diverse applications across multiple disciplines. Its unique structure, coupled with recent advancements in synthetic methodologies and pharmacological studies, positions it as a key player in future innovations within the chemical sciences.

• 502-47-6(3,7-dimethyloct-6-enoic acid)
• 18294-87-6(1-Cyclohexenylacetic acid)
• 18951-85-4((R)-(+)-Citronellic Acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)